PubMed HealthSearch

PubMed · 6868871

[Experiences with tocolysis].

Abstract

The results of tocolysis applied for delaying premature delivery and abortion is reported as well as its side effects in the mother. 168 patients were included in the study. It is stated that fenoterol can be successfully administered for stopping early contractions. The side effects of the drug are relatively mild and avoidable. It is also stated that fenoterol treatment is not superfluous even in case of a ruptured membrane when the fetal lungs are not ripe yet. Looking for combined possibilities should be the subject of future studies.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Szabó, L Bódis. 1983. [Experiences with tocolysis].. https://pubmed.ncbi.nlm.nih.gov/6868871/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A randomized crossover study using yohimbine and isoxsuprine versus pentoxifylline in the management of vasculogenic impotence.

PURPOSE: We evaluated the efficacy and safety of yohimbine and isoxsuprine or pentoxifylline in the management of vasculogenic erectile dysfunction. MATERIALS AND METHODS: A total of 20 patients diagnosed with arterial insufficiency and cavernous venous leakage by pharmacological penile duplex scanning underwent nonhormonal oral therapy. A randomized crossover study was performed using 5.4 mg. yohimbine plus 10 mg. isoxsuprine or 400 mg. pentoxifylline 3 times daily. Response to therapy was assessed by a sexual questionnaire and repeat penile duplex ultrasonography. RESULTS: No patient in either phase of the study in either group had a complete response to the oral regimen(s) and there was no improvement in the pre-injection or post-injection cavernous arterial peak systolic flow velocities or resistance indexes. CONCLUSIONS: Our study suggests that these oral agents, although well tolerated, were not effective in the management of these patients with mixed vasculogenic erectile dysfunction.

Administration, Oral